260 completed, 32 unknown, 20 recruiting, 15 terminated. 121 Phase 3, 63 Phase 4, 60 Phase 2, 47 Not applicable, 30 Phase 1.
Follow Myelitis: new trials by email Literature Review of Myelitis trials Research Report on Myelitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I/II Clinical Trial of the Diphtheria, Tetanus, Acellular Component Pertussis and Sabin Inactivated Poliomyelitis Vaccine Adsorbed Diphtheria, Tetanus, Acellular Component Pertussis and Sabin Inactivated Poliomyelitis Vaccine Adsorbed, Diphtheria, Tetanus and Acellular Component Pertussis Combined Vaccine, Diphtheria, Tetanus and Acellular Component Pertussis Combined Vaccine+Inactivated Poliomyelitis Vaccine Made From Sabin Strains - Diphtheria, Pertussis | Phase 1 / Phase 2 | Recruiting | Institute of Medical Biology, Chinese Academy of Medical Sciences | 380 | 2026-10-11 | 2026-10-23 |
| Study of BK1803 in Healthy Infants BK1803, GOBIK Aqueous Suspension Syringes, Bimmugen® Injection - Pertussis, Diphtheria | Phase 3 | Not yet recruiting | Tanabe Pharma Corporation | 344 | 2026-10-01 | 2026-08-28 |
| Safety and Immunogenicity of a Recombinant Poliomyelitis Vaccine (rPV) in Comparison With IPOL Vaccine in Healthy Adults Recombinant Poliomyelitis Vaccine (rPV), Inactivated Poliomyelitis Vaccine (IPOL) - Polio Immunity | Phase 1 | Recruiting | Serum Institute of India Pvt. Ltd. | 36 | 2026-09-11 | 2026-09-29 |
| Pattern of AFP in Chhidren Admitted at Sohag University Hospital Observitional follow-up - Acute Flaccid Paralysis, AFP | Not yet recruiting | Mohamed Aboelhamd Ali | 30 | 2026-09-01 | 2026-09-11 | |
| Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection Combination of Dolutegravir + Tenofovir DF for treatment of HTLV-1 infection, Dolutegravir (DTG) - HTLV-1 Infection, HTLV I Associated Myelopathies | Phase 2 | Recruiting | Carlos Brites | 146 | 2026-05-07 | 2026-06-02 |
| A Study to Evaluate the Mucosal Intestinal Immunity to Poliovirus Type-2 of nOPV2 at Birth Dose in Healthy IPV Vaccinated Infants nOPV2 - Poliomyelitis | Phase 3 | Recruiting | Fidec Corporation | 740 | 2026-04-30 | 2026-09-09 |
| Effects of Virtual Walking on Chronic Pain and Psychological Distress for Individuals With Severe Mobility Impairment Virtaul walking, Passive observing video - Severe Mobility Impairment, Spinal Cord Injuries (SCI) | Not applicable | Active not recruiting | The Hong Kong Polytechnic University | 48 | 2026-04-02 | 2026-09-15 |
| Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease Whole-body Electrical Muscle Stimulation Exercise - Neuromuscular Diseases (NMD), Amyotrophic Lateral Sclerosis | Not applicable | Recruiting | University of Missouri-Columbia | 50 | 2026-03-10 | 2026-03-17 |
| the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines Polio, Measles | Not yet recruiting | China National Biotec Group Company Limited | 600 | 2026-01-30 | 2026-01-14 | |
| Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine 2wIPV+1sIPV, 1wIPV+2sIPV, 3wIPV - Poliomyelitis | Phase 4 | Recruiting | Sinovac Biotech Co., Ltd | 480 | 2025-11-27 | 2026-03-09 |
| Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation Novel Oral Polio Vaccine Type 1 (nOPV1), Novel Oral Polio Vaccine Type 2 (nOPV2), Placebo (Sterile Water) - Poliomyelitis | Phase 2 | Recruiting | PATH | 675 | 2025-11-11 | 2026-01-09 |
| Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations sIPV, DTaP-IPV-Hib - Poliomyelitis | Phase 4 | Recruiting | Sinovac Biotech Co., Ltd | 180 | 2025-09-26 | 2026-01-21 |
| Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX) High-dose corticosteroids (HDCS), High-dose corticosteroids (HDCS) and PLEX - Optic Neuritis, Myelitis | Phase 3 | Recruiting | Mayo Clinic | 382 | 2025-07-11 | 2026-09-24 |
| A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series LBVD, Pentavalent vaccine and Inactivated Polio vaccine - Diphtheria, Tetanus | Phase 2 / Phase 3 | Active not recruiting | LG Chem | 1186 | 2025-05-30 | 2026-09-03 |
| Study of Concomitant Administration of the sIPV and DTaP or MMR sIPV, DTaP, bOPV 1,3 - Polio, Diphteria, Tetanus and Pertussis | Phase 4 | Not yet recruiting | Institute of Medical Biology, Chinese Academy of Medical Sciences | 2640 | 2025-05-15 | 2025-04-17 |
| The Impact of 'Digital Strolling' on Depression and Quality of Life of People With Severe Mobility Impairment Virtual walking, Passive observing walking - Severe Mobility Impairment, Spinal Cord Injuries (Complete and Incomplete) | Not applicable | Completed | The Hong Kong Polytechnic University | 24 | 2025-05-09 | 2026-05-19 |
| Immunogenicity of Different Primary Immunization Schedules with Inactivated Poliovirus Vaccine (IPV) Plus Pentavalent Vaccine (DTwP-HBV-Hib) or with Hexavalent Vaccine (DTwP-HBV-Hib-IPV) Pentavalent vaccine, Hexavalent vaccine, Inactivated poliovirus vaccine (IPV) - Polio | Phase 4 | Not yet recruiting | International Centre for Diarrhoeal Disease Research, Bangladesh | 1190 | 2025-01-28 | 2024-12-27 |
| A Study to Evaluate the Safety and Immunogenicity of VLP-Polio in Infants and Toddlers Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) (VLP-Polio) low adjuvant dose, VLP-Polio medium dose, VLP-Polio high dose - Poliomyelitis | Phase 1 / Phase 2 | Active not recruiting | CanSino Biologics Inc. | 480 | 2024-12-19 | 2026-08-06 |
| Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Novel oral poliomyelitis vaccine type 1 (nOPV1), Novel oral poliomyelitis vaccine type 2 (nOPV2), Novel oral poliomyelitis vaccine type 3 (nOPV3) - Poliomyelitis | Phase 1 / Phase 2 | Recruiting | PATH | 2400 | 2024-11-20 | 2025-06-03 |
| Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age LR20062, DTaP-HepB-IPV-Hib vaccine - Diphtheria, Tetanus | Phase 2 | Unknown | LG Chem | 336 | 2024-10-02 | 2024-10-01 |
Showing 20 of 349. Sign in to see all of them.
Poliomyelitis (263) · Diphtheria (114) · Tetanus (114) · Whooping Cough (81) · Haemophilus Infections (71) · Hepatitis B (68) · Myelitis, Transverse (32) · Postpoliomyelitis Syndrome (28) · Paraparesis, Tropical Spastic (23) · Multiple Sclerosis (19) · Neuromyelitis Optica (17) · Spinal Cord Injuries (15) · Optic Neuritis (13) · HTLV-I Infections (9)
Central Nervous System Diseases (349) · Central Nervous System Infections (349) · Neuroinflammatory Diseases (349) · Infections (347) · Nervous System Diseases (347) · Spinal Cord Diseases (347) · RNA Virus Infections (308) · Virus Diseases (302) · Neuromuscular Diseases (287) · Enterovirus Infections (284) · Picornaviridae Infections (284) · Bacterial Infections and Mycoses (119) · Gram-Positive Bacterial Infections (119) · Actinomycetales Infections (115)
Poliovirus Vaccine, Inactivated (28) · diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (27) · Tetanus Toxoid (14) · Diphtheria-Tetanus-acellular Pertussis Vaccines (11) · Pentavac (11) · DTaP-IPV-HB-PRP-T vaccine (10) · Heptavalent Pneumococcal Conjugate Vaccine (8) · pentacel (8) · 13-valent pneumococcal vaccine (7) · RIX4414 vaccine (7) · Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate (6) · Aging (5) · Poliovirus Vaccine, Oral (5) · diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis -Haemophilus influenzae type b conjugate vaccine (5) · Hepatitis B Vaccines (4)
GlaxoSmithKline (44) · Sanofi Pasteur, a Sanofi Company (42) · Sanofi (15) · Sinovac Biotech Co., Ltd (15) · Centers for Disease Control and Prevention (14) · Aga Khan University (12) · National Institute of Neurological Disorders and Stroke (NINDS) (11) · Fidec Corporation (10) · Institute of Medical Biology, Chinese Academy of Medical Sciences (8) · LG Chem (8) · PATH (8) · Merck Sharp & Dohme LLC (5) · Alexion Pharmaceuticals, Inc. (4) · Centers for Disease Control and Prevention, China (4) · International Centre for Diarrhoeal Disease Research, Bangladesh (4)
United States (63) · China (51) · Bangladesh (20) · Germany (16) · South Korea (15) · Canada (14) · France (14) · Japan (12) · United Kingdom (12) · Pakistan (11) · Italy (10) · Panama (10) · Philippines (10) · Poland (9) · Spain (9)
Ingrid Kromann (4) · Yuemei Hu (4) · Benjamin Greenberg, MD (3) · Steven Jacobson, Ph.D. (3) · Abhijeet Anand, MBBS, MPH (2) · Beth Kirkpatrick, M.D. (2) · Fengcai Zhu, Master (2) · Li Rongcheng, MD (2) · Michael Levy, MD, PhD (2) · Orla Hardiman, BSc MB BCh BAO MD FRCPI FAAN (2)
PMID 26873055, PMID 32867698, PMID 22153001, PMID 28340322, PMID 32273184, PMID 33487470, PMID 33676197, PMID 34498507, PMID 38218668, PMID 39088987, PMID 40318674, PMID 10025486, PMID 10625901, PMID 11459743, PMID 12236201, PMID 12522449, PMID 12691631, PMID 15472843, PMID 16713921, PMID 16831964, PMID 16984654, PMID 17090650, PMID 17152004, PMID 17376384, PMID 17429085, PMID 17717136, PMID 17990291, PMID 18256991, PMID 18816600, PMID 19117896, PMID 19252779, PMID 19578703, PMID 19952980, PMID 20035902, PMID 20448468, PMID 20573027, PMID 20616762, PMID 20818891, PMID 20955461, PMID 21219984, PMID 21289531, PMID 21334243, PMID 21343468, PMID 21372751, PMID 21441781, PMID 21807056, PMID 21965433, PMID 22001281, PMID 22157567, PMID 22158682
2014 (4), 2019 (4), 2018 (2), 2009 (1), 2015 (1), 2017 (1), R01NR016942 (1)